학술논문

68P Clinical implications of cardiotoxicity and pharmacokinetics of alectinib in patients (pts) with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC).
Document Type
Article
Source
Annals of Oncology. 2022 Supplement 2, Vol. 33, pS63-S63. 1p.
Subject
*ANAPLASTIC lymphoma kinase
*NON-small-cell lung carcinoma
*PHARMACOKINETICS
*CARDIOTOXICITY
Language
ISSN
0923-7534